Hoe kunnen biomarkers bijdragen aan het indiceren van individuele behandelingen van stress gerelateerde stoornissen?
Stress-related disorders like psychosis, depression, anxiety and addiction have a worldwide impact on mental and physical health. New strategies in personalized health care by determining individual sensitivity and optimally combining pharmacological, psychotherapeutic and neuromodulatory approaches are needed. As closely collaborating interdisciplinary researchers we aim to decrease the burden of these highly prevalent disorders by a better understanding of their development, characteristics and consequences. We aim to develop both new biomarkers and individualized treatments.